Vaccine Preventable Disease and Vaccine Hesitancy.
Med Clin North Am
; 107(6): 979-987, 2023 Nov.
Article
em En
| MEDLINE
| ID: mdl-37806729
ABSTRACT
Global immunization programs have saved tens of millions of lives over the last 2 decades. Now, the recent successes of COVID-19 vaccines having saved more than 3 million lives in North America during the pandemic may open the door to accelerate technologies for other emerging infection vaccines. New vaccines for respiratory syncytial virus, norovirus, influenza, herpes simplex virus, shingles, dengue fever, enteric bacterial infections, malaria, and Chagas disease are advancing through clinical development and could become ready for delivery over the next 5 years. The successful delivery of these new vaccines may require expanded advocacy and communications efforts.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Contexto em Saúde:
1_ASSA2030
/
2_ODS3
/
3_ND
/
4_TD
Problema de saúde:
1_doencas_nao_transmissiveis
/
1_doencas_transmissiveis
/
2_enfermedades_transmissibles
/
2_muertes_prematuras_enfermedades_notrasmisibles
/
3_chagas_disease
/
3_dengue
/
3_malaria
/
3_zoonosis
/
4_chagas
/
4_dengue
/
4_malaria
/
4_pneumonia
Assunto principal:
Vacinas contra Influenza
/
Vacinas
/
Doenças Preveníveis por Vacina
/
COVID-19
Limite:
Humans
Idioma:
En
Revista:
Med Clin North Am
Ano de publicação:
2023
Tipo de documento:
Article